Sorafenib/2800Z Co-Loaded into Cholesterol and PEG Grafted Polylysine NPs for Liver Cancer Treatment

The treatment of liver cancer remains challenging due to the low responsiveness of advanced cancer to therapeutic options. Sorafenib is the first line chemotherapeutic drug for advanced liver cancer but is frequently associated with severe side effects lead to discontinuation of chemotherapy. We pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chen, Zhong, Wu, Cao, Ying, Liu, Bohao, Tao, Xiaojun, Li, Zhuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865580/
https://www.ncbi.nlm.nih.gov/pubmed/36678616
http://dx.doi.org/10.3390/ph16010119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865580/
https://www.ncbi.nlm.nih.gov/pubmed/36678616
http://dx.doi.org/10.3390/ph16010119

Ejemplares similares